The Radiotherapy Market is estimated to be valued at US$ 7560.28 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Radiotherapy involves using high doses of radiation to treat cancer and tumors. It works by damaging the DNA of cancer cells and stopping them from dividing and spreading in the body. There are various radiotherapy techniques such external beam radiotherapy, internal radiation therapy, proton therapy and stereotactic therapy which are used depending on the type, location and stage of cancer. Radiotherapy provides non-invasive treatment option and is often used in combination with surgery or chemotherapy. Market key trends: Technological advancements are expected to be a major driver for the radiotherapy market. Key players are increasingly investing in development of advanced radiotherapy systems such as proton therapy, stereotactic radiosurgery systems and image-guided radiotherapy technologies. Proton therapy offers more focused and precise dose delivery to cancer tumors with reduced damage to surrounding tissues. Vendors are also developing compact proton therapy systems to increase accessibility and reduce costs. Adoption of artificial intelligence is allowing integration of imaging techniques with radiotherapy to improve treatment accuracy and precision. This is expected to boost demand for radiotherapy systems over the forecast period. Porter’s Analysis Threat of new entrants: The threat of new entrants is moderate as it requires high capital investments to set up the infrastructure required for radiotherapy equipment and associated facilities. The existing players have strong brand recognition and economies of scale. Bargaining power of buyers: The bargaining power of buyers is moderate as the need for radiotherapy services is non-discretionary. However, the buyers can negotiate on the pricing and payment terms with suppliers and service providers. Bargaining power of suppliers: The bargaining power of suppliers is low as there are multiple equipment manufacturers in the market. The suppliers do not have control over pricing. Threat of new substitutes: There is a low threat from substitutes as radiotherapy remains the primary treatment option for cancer patients. Competitive rivalry: The competitive rivalry in the market is high due to the presence of numerous global and regional players. SWOT Analysis Strength: The radiotherapy market is driven by the increasing prevalence of cancer globally. It offers minimally invasive and targeted treatment options. Weakness: High dependency on capital equipment results in lengthy upgrade cycles. Stringent regulatory approvals delay new product launches. Opportunity: Emerging economies present lucrative growth prospects due to growing healthcare investments. Technological advancements will support non-invasive procedures. Threats: Social stigma around cancer treatment discourages patients. Lack of skilled professionals hampers market growth. Key Takeaways The global Radiotherapy Market Share is expected to witness high growth at a CAGR of 6.8% over the forecast period, driven by the increasing prevalence of cancer worldwide. According to Globocan 2020, cancer burden has risen to 19.3 million cases and 10 million cancer deaths in 2020. Regionally, the market in Asia Pacific is anticipated to grow at the fastest rate owing to rising healthcare expenditures, huge patient population and increasing demand for better cancer facilities. China, India and Japan are likely to experience significant increase in installation of radiotherapy systems in the coming years. Key players operating in the radiotherapy market are Accuray Incorporated, Elekta, Isoray Inc., CIVCO, Hitachi, Ltd., Mevion Medical Systems, ProTom International, VIEWRAY TECHNOLOGIES, INC., Panacea Medical Technologies Pvt. Ltd., Optivus Proton Therapy, Inc., RefleXion, MacroMedics, Vision RT Ltd., and Qfix. The major players are focusing on developing innovative product technologies and strategic collaborations with hospitals.
Read More,
https://www.newsstatix.com/radiotherapy-market-trends-size-and-share-analysis/
This report aims to provide detailed insights into the global radiotherapy market.
It provides valuable information on the type, procedure, application, and region in the market.
Expected Revenue Growth: [259 Pages Report] The radiotherapy market is valued at USD 5.9 billion in 2021 and is expected to reach USD 7.3 billion by 2026, at a CAGR of 4.2% Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567 Key Factors Driving Market Growth: Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this radiation oncology market.
Additionally, the growing adoption of radiotherapy procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and the rising number of conferences and symposia focusing on the advancements in radiotherapy are some of the other major factors driving the growth of radiotherapy market.
These advancements have helped in the development of more effective, low-cost, and easy-to-use radiotherapy products with improved and precise radiation dose delivery to offer increased efficiency in targeting tumors.
The advancement from 2D to 3D conformal radiotherapy with real-time imaging has enabled high conformity of radiation to the target (with minimal exposure to normal tissue) and dose escalation with improved tumor control.
Radiotherapy Market Research Report: Information by Type [External Beam Radiation Therapy (Intensity Modulated Radiation Therapy, Image Guided Radiation Therapy, Tomotherapy, Stereotactic Radio Surgery, Stereotactic Body Radiation Therapy, and Proton Therapy), Internal Radiation Therapy and Systemic Radiation Therapy], Application (Skin and Lip Cancer, Head and Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Spine Cancer, and others), Equipment (Linear Accelerators, Radiation Therapy Simulators and Treatment Planning Systems), End-User (Hospitals and Independent Radiotherapy Centers) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Global Forecast till 2027Radiotherapy Market HighlightsRadiotherapy or radiation therapy is a treatment designed to reduce the size of tumors, blood disorders, and thyroid disease.
The global radiotherapy market report by Market Research Future (MRFR) contains useful insights deemed to assist market players in their strategies for the period between 2019 to 2025 (forecast period).Market OutlookThe global radiotherapy market size is expected to showcase a CAGR of 4.7% during the forecast period due to high prevalence of cancer cases.
The preference of radiotherapy as a line of treatment for reducing and eliminating malignant tumors can drive the market growth.
Technological advances in radiation therapy as well as continuous clinical trials for testing new drugs to reduce the effects of the treatment can bode well for the market.Adoption of radiotherapy for the treatment of various cancers as well as procurement of latest devices and drugs for palliative care of cancer patients can spur the market demand till 2025.
Government investments in research of radiotherapy can facilitate market growth.However, low access as well as unavailability of treatments at affordable prices can hamper market growth.Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/1526SegmentationThe global radiotherapy market has been segmented based on type, application, end user, and region.The global radiotherapy market, based on type, has been segmented into external beam radiation therapy, internal radiation therapy, and systemic radiation therapy.
On the basis of the type segment, the external beam radiation therapy segment is expected to hold a major share in the market due to the reduced risk of radiation exposure during the treatment and the increased precision and accuracy of tumor targeting.The global radiotherapy market, based on application, has been segmented into skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, spine cancer, and others.The global radiotherapy market, based on equipment, has been segmented into linear accelerators, radiation therapy simulators, and treatment planning systems.The global radiotherapy market, based on end use, has been segmented into hospitals and independent radiotherapy centers.Regional Analysis Based on region, the radiotherapy market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).The Americas is expected to dominate the global radiotherapy market due to novel treatment discovered in targeted therapy and the rise in per capita expenditure in healthcare.
